NCT02996383

Brief Summary

In England each year over 70,000 people fracture their hip. Most of these patients are elderly females with the fracture occurring after a simple trip or stumble. Approximately half of these fractures are classified from their relationship to the hip joint capsule as intracapsular. These fractures are subdivided into those that are displaced and those that are undisplaced. The majority of displaced fractures are treated with a replacement arthroplasty. Current treatment for the undisplaced fractures is generally by internal fixation of the fracture using screws and a plate, although some centres prefer replacement arthroplasty. A recent randomised study on patients from Norway with undisplaced intracapsular fractures treated with either internal fixation or arthroplasty has just reported reduced complications and re-operations for those patients treated with an arthroplasty. In addition functional results were marginally better for those patients treated with an arthroplasty. Current practice in the UK is generally to treat these fractures by internal fixation. This study aims to see if replacement arthroplasty can indeed lead to the advantages suggested from the Norwegian study. Patients who satisfy the inclusion criteria and are willing to participate will be randomised to receive either reduction and internal fixation of the fracture with a screw and plate device or alternatively replacement of their femoral head with an artificial hip replacement (hemiarthroplasty). After surgery patients will receive the same treatment as normal and be discharge home when able, with follow-up review in the hip fracture clinic. Subsequent follow-up for the research project is by phone calls from a research nurse who is blinded to the type of treatment that the patient has received. There will be no additional investigations or out-patient follow-up visits for these patients in comparison to normal treatment protocols. Results of the study will ultimately be published in a medical journal.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 10, 2016

Completed
6 months until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Last Updated

December 19, 2016

Status Verified

December 1, 2016

Enrollment Period

3.3 years

First QC Date

June 10, 2016

Last Update Submit

December 16, 2016

Conditions

Keywords

arthroplasty

Outcome Measures

Primary Outcomes (1)

  • regain of mobility using the Parker and Palmer mobility scale

    Assessment is using the Parker and Palmer mobility score (Parker MJ, Palmer CR. A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br. 1993;75:797-8.)

    one year

Study Arms (2)

Cemented hemiarthroplasty

ACTIVE COMPARATOR

Treatment of the fracture by a replacement arthroplasty with a cemented CPT hemiarthroplasty (manafactured by Zimmer company, Warsaw IN, USA) inserted via an anteriolateral approach to the hip

Device: Cemented Hemiarthroplasty

Internal fixation

ACTIVE COMPARATOR

Internal fixation of the fracture with a screw and plate device (Targon FN plate, Aesculap cooperation, Tuttingham, Germany)

Device: Internal fixation

Interventions

Internal fixation of the fracture with a Targon FN implant (BBraun Ltd, Germany)

Internal fixation

Replacement of the femoral head with a cemented hemiarthroplasty

Cemented hemiarthroplasty

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

  • patients who decline to participate or in whom consent or assent is not available
  • patients admitted when MJP is not available to supervise treatment
  • patients with pathological fractures from Paget's disease of bone secondary's from tumour
  • patients with delayed presentation who would be treated conservatively
  • patients considered unfit for either surgical procedure
  • younger patients, aged less than 80 years who are independently mobile and very active will be excluded at treated by internal fixation (the risk of fracture healing complication for this group is less, whilst there is an increased risk of long term complications after arthroplasty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peterborough and Stamford Hospital NHS Foundation Trust

Peterborough, Cambs, PE36DA, United Kingdom

RECRUITING

MeSH Terms

Conditions

Hip Fractures

Interventions

Fracture Fixation, Internal

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Fracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
consultant orthopaedic surgeon

Study Record Dates

First Submitted

June 10, 2016

First Posted

December 19, 2016

Study Start

May 1, 2016

Primary Completion

September 1, 2019

Last Updated

December 19, 2016

Record last verified: 2016-12

Locations